KCNK4 and stroke disorder: Because administration of taurine failed to significantly increase the level of this aminoacid in the human brain [31], we suggest that the cerebroprotective effects resulting from TRAAK deletion should prompt the search for selective blockers of TRAAK [89] for preventive or therapeutic treatments against stroke